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Abstract
Critical to an understanding of the pulmonary disease in cystic
fibrosis (CF) and the development of effective gene therapies is
a definition of the distribution and regulation of CF gene ex-
pression in adult human lung. Previous studies have detected
the product of the CF gene, the CF transmembrane conduc-
tance regulator (CFTR), in submucosal glands of human bron-
chi. In this report, we have characterized the distribution of
CFTR RNA and protein in the distal airway and alveoli of hu-
man lungs. Samples from eight human lungs were analyzed for
CFTR expression by in situ hybridization and immunocyto-
chemistry. CFTR was detected in a subpopulation of epithelial
cells at every level of the distal lung, including proximal, termi-
nal, and respiratory bronchioles, and the alveoli. However,
there was substantial variation in the level ofCFTR expression
between samples. In bronchioles, CFIR protein localized to the
apical plasma membrane and was found primarily in a subpopu-
lation of nonciliated cells. CFIR was expressed in the same
distribution as the Clara cell marker CC10 in proximal bron-
chioles, however, expression was discordant in the more distal
bronchioles and alveoli where- CC10 was not detected. These
studies suggest that epithelial cells of the distal lung may play a
primary role in the pathogenesis of CF as well as expand the
spectrum of target cells that should be considered in the devel-
opment of gene therapies. (J. Clin. Invest. 1994. 93:737-749.)
Key words: CFIR * mRNA * localization * Clara - airway
Introduction
Cystic fibrosis (CF)' is the number one genetic cause of death
in the Caucasian population ( I ). Although multiple organs are
affected in this disease, the most morbid and life threatening
pathology occurs in the lung. Poor mucociliary clearance with
excessive mucous production causes obstructive lung disease
and chronic bacterial infections leading to bronchiectasis and
respiratory failure. Isolation of the gene responsible for CF has
provided insight into the molecular basis of this disease (2).
The product of this gene, called the CF transmembrane con-
ductance regulator (CFTR), is a chloride channel that is pri-
marily localized to the apical surface of epithelial cells. Mecha-
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nisms by which mutations in this gene lead to primary defects
in mucociliary clearance remain obscure.
Critical to an understanding of the basic molecular pathol-
ogy of CF pulmonary disease is a definition of the normal dis-
tribution and regulation of CFTR expression in lung. Studies
ofCFTR expression in proximal airway structures such as hu-
man bronchus and nasal tissue have shown low levels ofCFTR
mRNA and protein in cells ofthe surface epithelium (3-5). In
contrast, high levels of CFTR were demonstrated in epithelial
cells of human submucosal glands that are normally restricted
to the very proximal airway that is supported with cartilage (6).
While these studies provide insight into pathophysiology ofCF
in the proximal airway, their relationship to disease in the
bronchioles and alveoli is unclear. A previous report using in
situ hybridization of human fetal lungs suggests that CFTR
mRNA levels are extremely high prenatally and decline dramat-
ically after birth (7).
The distal lung can be divided into the conducting airways,
which are comprised of an extensive network of bronchioles,
and alveoli, where gas exchange with the blood occurs (8).
Four general structures can be identified based on morphologi-
cal criteria: (a) proximal bronchioles, which have a pseudostra-
tified epithelium but in contrast to bronchi do not contain
cartilage; (b) terminal bronchioles, which have a simple col-
umnar to cuboidal epithelium; (c) respiratory bronchioles,
which have a discontinuous simple cuboidal epithelium in-
terrupted by alveoli and alveolar ducts; and (d) alveoli, the
gas-exchanging region of the lungs (8). Proximal bronchioles
provide a transition from cartilaginous bronchi and contain
decreasing percentages of basal cells and secretory cells as the
lumen reduce in size. Smaller bronchioles normally contain
only ciliated cells and nonciliated secretory cells (Clara cells),
which decrease in height and appear cuboidal in most distal
bronchioles. The respiratory bronchioles, which provide the
transition between conducting airways and gas-exchanging al-
veoli, are interrupted by alveoli and alveolar ducts and contain
predominantly cuboidal Clara cells with decreasing numbers of
ciliated cells. The alveolar epithelium is composed of alveolar
type I and II cells.
We report the localization ofCFTR mRNA and protein in
distal airways and alveolar regions of human lung. In an at-
tempt to identify the cell types that express CFTR in the distal
airway, we have compared the pattern of mRNA expression
with the Clara cell marker CC10. These studies have implica-
tions to the pathophysiology of CF lung disease as well as the
design of rational gene therapies.
Methods
Lung samples. Tissue specimens were obtained from the lungs ofeight
patients under a variety of circumstances. Table I summarizes salient
features of the donors from which the tissues were derived. Two sam-
ples were obtained at the time of surgical lobectomy for lung cancer;
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nontumorous resected regions were selected for analysis, however, each
patient had evidence of chronic obstructive pulmonary disease
(COPD). These tissues were placed on ice immediately after resection
and frozen in OCT within 30 min. The remaining samples were ob-
tained in the setting of lung transplantation. Two samples (Normal I
and Normal2) were obtained from portions of donor lungs that were
not used for transplantation. These specimens were perfused with Uro
Collins solution and stored for 0.5-4 h on ice. The Normal 1 sample
was excised from a resected lung after perfusion in the transplant recipi-
ent. Both were frozen in OCT within 30 min of resection. The remain-
ing four samples, COPD1, COPD2, IB, and PAP, were derived from
the diseased lungs ofthe transplant recipients who were diagnosed with
COPD, idiopathic bronchiectasis, and pulmonary alveolar proteinosis,
respectively. These samples were also frozen in OCT within 30 min of
resection. All samples were stored at 134IC until they were sectioned.
In situ analysis ofCFTR and CCJO mRNA. Frozen sections (6 Mum)
were fixed in PBS containing 4% paraformaldehyde for 3-4 h followed
by dehydration through a graded series ofethanol. In situ hybridization
was performed as described previously (6). Briefly, dehydrated fixed
sections were treated in 10 ug/ml proteinase-K at 30C for 30 min
followed by acetylation in acetic anhydride and dehydration through a
graded series of ethanol. Sections were hybridized to UTP and CTP
"S-labeled sense and antisense RNA probes generated from the CFTR
R-domain ( 1,899-2,623 bp [9]) and CCl0 ( 1-361 bp [10]) cDNAs at
a concentration of I07 cpm/ml for 16-18 h at 540C. After washing and
RNAse treatment, sections were coated in NTB-2 photoemulsion and
developed at indicated times. An additional control for nonspecific
hybridization included pretreatment of sections with 200 gg/ml
RNAse A before hybridization with antisense probes.
Immunofluorescent detection of CFTR and Na+/K+-A TPase.
CFTR protein was localized as previously described using a polyclonal
antibody generated against a COOH-terminal peptide of CFTR (resi-
dues 1468-1480) designated a-1468 (6). Na+/K+-ATPase was local-
ized using a mouse monoclonal antibody to the purified alpha subunit
of Na+/K+-ATPase ( I1 ). Briefly, frozen sections (6 tim) were fixed in
-20°C methanol for 10 min followed by air drying. Sections were
blocked with PBS containing 20% donkey serum (DS) and protease
inhibitors (2.5 ,g/ml of soybean trypsin inhibitor and 1 qg/ml each of
leupeptin, chymostatin, pepstatin, and aprotinin) for 30 min at room
temperature. Sections were then incubated sequentially in 5 /g/ml
a- 1468 CFTR antibody and protease inhibitors for 90 min followed by
incubation in undiluted hybridoma supernatantagainstNa+/K+-ATP-
ase for 60 min. After washing in 1.5% DS/PBS, sections were incu-
bated in 5 ,g/ml of both donkey anti-rabbit FITC-conjugated anti-
body and donkey anti-mouse Texas red-conjugated antibody for
30 min.
Peptide competition experiments were performed by preincubating
0.5 mg/ml peptide (residues 1468-1480 of CFTR protein) with 0.25
mg/ml of a- 1468 in PBS containing 1.5% DS and protease inhibitors
overnight at 4°C before immunofluorescent staining. Control uncom-
peted antibody was incubated under the same conditions but without
peptide. Bronchioles were analyzed for peptide-competed signal in se-
rial sections. Additional sections were incubated with and without sec-
ondary antibody to control for nonspecific secondary antibody binding
and autofluorescence, respectively.
Quantification of CFTR mRNA expression. Morphometry of
CFTR in situ data involved analysis of at least four sections from each
ofthe human lung samples analyzed. Identification ofairway epithelial
structures were based on the following criteria: proximal bronchiole,
noncartilaginous airway with a pseudostratified epithelium; terminal
bronchiole, airway with a simple columnar/ cuboidal epithelium that is
not interrupted by alveolar ducts; respiratory bronchiole, small diame-
ter airway with a simple cuboidal epithelium that is interrupted by
alveolar ducts; and alveoli-composed of cuboidal type II and squamous
type I cells. At least six random fields ofeach structure (proximal bron-
chiole, terminal bronchiole, respiratory bronchiole, and alveoli) were
analyzed for the frequency of cells expressing CFTR mRNA > 10-fold
above background levels ofCFTR mRNA. Sections were analyzed for
total number of CFTR mRNA-expressing cells per total number of
nuclei in each structure and total number ofCFTR mRNA expressing
cells per square micron of total cellular area in each structure. CFTR
mRNA-expressing cells were selected as those cells that expressed
> 10-fold abundance of grains as compared with acellular regions in
the same field. Cellular volumes and total numbers of cells were calcu-
lated from outlined epithelial regions of proximal bronchioles, termi-
nal bronchioles, respiratory bronchioles, and alveoli. Four of the eight
samples analyzed were quantitated. Because of the high levels of
mRNA expressed in a subset of cells, darkfield photomicrographs
tended to be misleading in quantification due to bleeding of the satu-
rated signal. Hence, only bright field photomicrographs were used for
quantification. Results are presented as the average ± 1 SD. Statistical
comparison was performed by the Student's t test.
Due to the limiting quantities ofCFTR antibody, only one section
from each sample was analyzed. This gave insufficient numbers of
sections and independent bronchioles to analyze for quantification.
The same criteria as used with in situ hybridization were used for the
identification of proximal and terminal bronchioles. Extensive auto-
fluorescence in the most distal regions ofthe lung made it impossible to
accurately address CFTR expression in the respiratory bronchioles and
alveolar regions.
Results
CFTR mRNA localization. The cellular distribution ofCFTR
mRNA in lung was analyzed by in situ hybridization using an
RNA probe to the R domain of human CFTR. Fig. 1 contains
representative examples from two patients of in situ hybridiza-
tion to proximal bronchioles (A-C), terminal bronchioles (D-
G), respiratory bronchioles (H-J), and alveolar regions (K-
M). Each sample demonstrated hybridization to the antisense
probe that was not present when the sample was pretreated
with RNAse (data not shown) or when it was hybridized to a
sense probe (Fig. 1, A, D, H, and K). In general, hybridization
was restricted to a subset of epithelial cells found in both airway
and alveoli. Table II summarizes the quantification of the fre-
quency of highly positive cells (> 10-fold above background;
see Fig. 1 G for example) found at each level ofthe airway from
four of the eight patients. Morphometric analyses were used to
quantitate the frequency of highly expressing cells normalized
to either cell number (number ofpositive cells/number oftotal
nuclei) and cell volume (number of positive cells/Am2 cell
volume) within each of the epithelial structures analyzed. Al-
though the frequency of highly positive cells normalized to
total cell numbers remained similar among the eight samples
Table I. Lung Samples
Donor Age Sex Disease Source
yr
Normal 1 47 F Normal Transplant
Normal2 42 M Normal Transplant
COPD1 50 F COPD* Transplant
COPD2 57 F COPD Transplant
COPD3 65 M COPD Lobectomy
COPD4 70 F COPD Lobectomy
IB 23 F IBt Transplant
PAP 41 F PAP§ Transplant
* Chronic obstructive pulmonary disease. * Idiopathic bronchiecta-
sis. § Pulmonary alveolar proteinosis.
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Figure 1. Localization ofCFTR mRNA in human lung. Tissue sections of human lung were analyzed for expression ofCFTR mRNA by in situ
hybridization. These include proximal bronchioles: samples PAP (sense [A] and antisense [B]) and Normal2 (antisense [C]); terminal bron-
chioles: samples Normal2 (sense [D] and antisense [El) and PAP (antisense [Fand Gi); respiratory bronchioles: samples Normal2 (sense [H]
and antisense [I]) and PAP (antisense [J]); and alveoli: sample Normal2 (sense [K] and antisense [LI) and PAP (antisense [M]). Sections hy-
bridized with the sense probe are serial to the sections hybridized with the corresponding antisense probe. All panels show 3-wk exposures to
photoemulsion with brightfield and darkfield photomicrographs on the left and right, respectively, except for G, which shows two higher power
photomicrographs of terminal bronchioles. Arrows point to a subset of cells that intensely express CFTR within the alveolar regions of L and
M and respiratory bronchial epithelial cells of I and J (A-F, J, K, and K-M: bar = 130 Mm; G: bar = 40 Am; H and I: bar = 65 pm; J. bar = 160
Am).
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(Table II), the intensity of signal varied significantly. Because
of the focal nature of the signal, it was impossible to quantify
differences between samples in the intensity of highly express-
ing cells due to saturated signal in the highest expressing sam-
ples. Evaluation ofthe proximal bronchioles illustrates the type
of variation in intensity and frequency that was encountered;
expression ranged from very high signal in 9±5% of epithelial
cells in sample PAP (Fig. 1 B) to signal that was barely above
background in 4±3% of epithelial in sample Normal2 (Fig. 1
C). This heterogeneity may reflect the clinical status of the















































donor or heterogeneity of expression within subsegments ofan lyzed. Table II summarizes the results and statistically com-
individual lung. pares the compiled data from four patients as to the abundance
In an attempt to quantitate the abundance of CFTR of CFTR-expressing cells within the various levels of the air-
mRNA-expressing cells in a manner that was not affected by way. In contrast to morphometric analysis normalized to total
differences in airway cellular architecture, we normalized mor- cell numbers, the number of CFTR-expressing cells normal-
phometric quantification to the total cell area ofstructures ana- ized to cell area gave a statistically higher (P < 0.001 ) level of



















Table II. Summary ofCFTR Localization: Frequency ofCFTR mRNA-expressing Cells
Proximal Terminal Respiratory
bronchioles bronchioles bronchioles Alveoli
Normalized to cell number* Normal2 4±3% 4±3% 10±10% 1±1%
COPD1 2±3% 3±3% 10±4% 2±3%
COPD3 3±2% 3±3% 5±5% 3±2%
PAP 9±5% 9±4% 7±4% 5±2%
Averaget 5±3 5±3 8±3 3±2
Normalized to cellular areal Normal2 1.7±1.3 1.6±0.9 4.2±4.4 0.2±0.2
COPD1 0.5±0.1 0.6±0.6 2.7±1.3 0.7±0.8
COPD3 1.2±0.8 1.4±1.4 1.5±1.5 0.4±0.3
PAP 1.2±0.4 2.6±1.4 2.1±1.1 0.9±0.4
Averagetdl 1.2±0.5 1.6±0.8 2.6±1.2 0.6±0.3
* The frequency of cells expressing > 10-fold levels ofCFTR mRNA above background was counted within each of the epithelial structures and
normalized to the total number of nuclei in that structure according to procedures described in Methods. Values representing averages from at
least six fields are given as number of positive cells per total number of nuclei ±1 SD. * The average of four patients analyzed by morphometry
for each epithelial structure (n = 24 fields). § The frequency of cells expressing > 10-fold levels of CFTR mRNA above background was
counted within each of the epithelial structures and normalized to the total cell volume within each structure according to procedures described
in Methods. Values representing the averages from at least six fields are given as number of positive cells per square micron of cellular area
(X 10-') ± 1 SD. 11 Statistical analysis using the Student's t test comparing the frequency of CFTR mRNA-positive cells in at least 24 fields of
each epithelial structures, proximal bronchioles (PB), terminal bronchioles (TB), respiratory bronchioles (RP), and alveoli (A); PB vs. TB, P <
0.127; PB vs. RB, P <0.017; PB vs. A, P < 0.035; TB vs. RB, P < 0.162; TB vs. A, P < 0.001; and RB vs. A, P <0.001.
CFTR mRNA-expressing cells in the respiratory bronchioles
as compared with proximal bronchioles and alveoli. No statis-
tical difference was found between the level of CFTR expres-
sion in terminal and respiratory bronchioles (P < 0.162).
No conclusions as to the cell type expressing CFTR in the
bronchioles could be made, as cilia were not retained after tis-
sue preparation for in situ analysis. However, in situ grains
were clustered in cells of the alveolar region that appeared cu-
boidal in shape, a finding most consistent with expression in
type II pneumocytes rather than the squamous type I pneumo-
cytes or intraalveolar macrophages (which were interpreted as
lying within the lumen of the airspace).
CFTR protein localization. Tissue sections were analyzed
for expression of CFTR protein using a polyclonal antibody
directed against a COOH-terminal peptide ofCFTR. The speci-
ficity and sensitivity of this antibody for immunolocalizing
CFTR in tissues has been described previously (6). The speci-
ficity of CFTR immunoreactive staining in bronchioles was
determined in single immunofluorescent experiments using se-
rial sections stained with CFTR antibody preincubated with
peptide antigen. Fig. 2, A and B, shows CFTR-immunoreac-
tive staining in a proximal and terminal bronchiole that was
absent when the antibody was preincubated with peptide anti-
gen (Fig. 2 C). Fluorescence signal was also absent when the
primary antibody was omitted (data not shown). Tissue sec-
tions were also incubated with antibodies to CFTR and an-
other membrane marker, the Na+/K+-ATPase, that localizes
to the basal lateral surface of epithelial cells. Fig. 3 contains
examples of CFTR expression in a proximal bronchiole (A)
and terminal bronchiole (B). CFTR antibody bound to a sub-
population ofairway epithelial cells in bronchioles offive ofthe
six samples analyzed; the signal consistently localized to the
apical surface of these cells. CFTR expression was primarily
observed in nonciliated cells, as visualized under Nomarski
optics (see arrows, Figs. 2 B and 3 A). However, in sections
where morphologic retention of the ciliated layer was inade-
quate, as indicated by compressed cilia, it was impossible to
exclude the possibility that high levels ofCFTR were also ex-
pressed in a subset of ciliated cells. CFTR protein localization
in respiratory bronchioles and alveolar regions was difficult
due to high levels of autofluorescence (which appears as a yel-
lowish-orange fluorescence on the FITC channel), as indicated
by fluorescent signal in FITC, Texas red, and UV channels of
sections not treated with secondary antibody. Nonspecific bind-
ing ofprimary antibody to endothelial cells ofalveolar capillar-
ies also made protein localization difficult in this region.
Hence, no conclusions at present can be made about the cell
type that expressed CFTR protein in respiratory bronchioles
and alveoli.
CCJO mRNA localization. In an attempt to further charac-
terize the cell type that expresses CFTR, three tissues samples
that showed high-level CFTR hybridization were also analyzed
for expression of the cell-specific marker CC10 by in situ hy-
bridization. This gene encodes a 10-kD secreted protein that is
believed to be specific to a subtype ofClara cells ( 10, 12). Very
high levels of hybridization to the antisense CC10 probe were
demonstrated in> 50% of the cells ofthe proximal bronchioles
(Fig. 4 B) of all three patients analyzed. Serial sections hybrid-
ized with the sense probe (Fig. 4 A) or pretreated with RNAse
before hybridization to the antisense probe (data not shown)
failed to demonstrate signal over background. Expression of
CC10 was substantially lower in the terminal and respiratory
bronchioles ofone sample (PAP; Fig. 4 B) and was absent from
these regions in the two other samples (Normal2 and COPD3;
data not shown). Signal was absent in the alveolar regions from
all samples analyzed.
To more closely analyze the potential overlap ofCC IO and
CFTR mRNA expression, serial sections from the three sam-
ples described above were hybridized to either the CC10 or
CFTR antisense mRNA probes. Fig. 5 illustrates the findings
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Figure 2. Peptide competition Of CFTR Protein localization in bronchioles. Immunocytochemical localization of CFTR protein expression in
lung sections was analyzed by peptide competition in serial section. (A) Pattern of CFTR expression detected with FITC within a proximal
bronchiole in the absence of peptide antigen. Shown are localization ofCFTR within serial sections of a terminal bronchioles in the absence of
peptide antigen (B) and after preincubation of the a 1468 antibody with peptide antigen (C). The open arrows mark a ciliated cell, while the



















































Figure 4. Localization of CCO0 mRNA. Sections from tissue sample PAP were hybridized to CCI0 sense (A) and antisense (B) RNA probes.
Shown are brightfield (left) and darkfield (right) photomicrographs. Photoemulsion was exposed for 18 h. tb, terminal bronchiole; arrows mark
pseudostratified bronchioles (bar = 260 tim).
with sample PAP, with representative examples of CC10 and
CFTR expression in proximal bronchioles (A and B) and al-
veoli (C and D). Several general observations emerged after
review of this sample. When present, the level ofCC 10 expres-
sion was dramatically higher than the level of CFTR expres-
sion. In all bronchioles, CFTR was expressed in the same re-
gions as CC I0. However, alveolar cells expressed CFTR in the
absence ofCCO expression. Analysis of the other two samples
(Normal2 and COPD3) revealed overlap ofCFTR expression
in a subset of CC10-expressing cells of the proximal bron-
chioles and a normal distribution ofCFTR expression with an
absence ofCC 10 expression in the terminal bronchioles, respi-
ratory bronchioles, and alveoli (data not shown).
Discussion
Despite tremendous insight into the genetic and molecular
basis of CF, little is known about the basic pathophysiology
that underlies the pulmonary manifestations ofthe disease. It is
generally believed that an important primary abnormality lies
in the conducting airways where defective mucociliary clear-
ance leads to obstructive lung disease and chronic infections
( 1 ). Critical to an understanding of these pathologic processes
is a knowledge of the distribution and regulation of CF gene
expression in adult human lung.
Previous studies have focused primarily on the expression
of CFTR in surface epithelial cells of proximal airway struc-
tures such as the nose, trachea, and bronchus. Functional evi-
dence for the existence of the CFTR chloride channel has been
demonstrated in surface epithelial cells of the proximal airway
( 13 ), however, attempts to detect and localize the CFTR pro-
tein and RNA have been difficult (3-5). One hypothesis is that
CFTR plays a role in the normal physiology ofthese cells but it
is expressed at very low levels (6). We recently characterized
the expression ofCFTR in human bronchus using techniques
of in situ hybridization and immunocytochemistry (6). Con-
sistent with previous studies, we found low levels ofCFTR in
the surface epithelium. However, substantial expression of
CFTR expression was found in serous cells and ducts of the
submucosal glands. This directly implicates an important mu-
cous-producing structure ofthe proximal lung in the pathogen-
esis of CF lung disease. It is unlikely that submucosal glands,
which are restricted to cartilaginous airway, play a direct role in
the extensive obstructive lung disease found in the distal airway
of patients with CF. In this report, techniques of in situ hybrid-
ization and immunocytochemistry were used to delineate the
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Figure 5. Localization ofCFTR and CCI0 mRNA in serial sections. Serial sections from sample PAP were hybridized to CCI0 (A and C) and
CFTR (B and D) antisense probes and developed for 18 h and 2 wk, respectively. Shown are brightfield (left) and darkfield (right) photomicro-
graphs. No signal was seen with either CC10 or CFTR sense probes or with RNAse-pretreated slides hybridized with antisense probe, data not
shown (A and B: bar = 260 Am; C and D: bar = 200 Mm).
distribution ofCFTR expression in distal airways and alveolar
regions of adult human lung.
This study demonstrates detect-able levels of CFTR RNA
and protein in a subpopulation ofepithelial cells in every struc-
ture distal to the bronchus, including proximal, terminal, and
respiratory bronchioles, and alveoli. Although the pattern of
expression within the lung was fairly consistent between pa-
tients, in that 1-10% highly expressing cells could be found
throughout all levels of the distal lung, the intensity of signal
varied substantially from patient to patient. This sample-speci-
fic variation in CFTR expression remains unexplained, but
could be related to environmental influences and/or heteroge-
neity of expression within subsegments of an individual lung.
The general pattern ofCFTR expression in the distal lung.
that emerged from our studies has implications in several areas
of CF biology. Morphometric analysis of CFTR-expressing
cells normalized to cellular area in the various airway struc-
tures shows a statistically significant trend that revealed highest
levels in respiratory bronchioles as compared with proximal
bronchioles (twofold, P < 0.001) and alveoli (fivefold, P
< 0.001 ). Comparison ofterminal and respiratory bronchioles
showed no statistical differences in the abundance of CFTR
mRNA-expressing cells, suggesting that these structures may
be functionally related in their capacity to facilitate CFTR-me-
diated chloride transport. An additional recurrent finding was
that CFTR did not appear to be expressed uniformly through-
out the lung, in that a minority of highly expressing cells ( 1-
10% of total cells) can be seen in bronchioles and alveoli. This
is reminiscent ofthe pattern ofCFTR expression in the submu-
cosal gland ducts of human bronchus where 1-2% of the duct
cells expressed high levels (> 50 fold over background) of
CFTR mRNA and protein (6). This pattern of expression is
consistent with regulation of chloride transport through a mi-
nority subpopulation of cells in a heterogeneous epithelium.
Models of this type of chloride transport regulation have been
extensively studies in systems such as the amphibian skin
where mitochondria rich flask cells, which constitute 1-2% of
the entire dermal layer, are the sole route of chloride uptake
(14, 15).
In the bronchioles it is clear that ciliated cells do not express
detectable levels ofCFFR protein, suggesting that other cells in
these epithelia may be involved in CFTR expression. The dis-
tribution and biology of nonciliated cells of human distal air-
way are not well described. Extrapolation from studies in non-
human primates ( 16) suggests that the distal airways contain a
variety ofcell types, including ciliated cells, mucous cells, basal
cells, and nonciliated secretory cells containing electron-dense
granules (also known as Clara cells [ 17 ]). Our analysis ofprox-
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imal bronchioles demonstrated extensive expression of the
Clara cell marker CC 10 within regions that also express CFTR
(see Fig. 6 for summary). The resolution of this analysis was
insufficient to study colocalization at a cellular level. However,
the lack ofcomplete concordance between CFTR and CC 10 in












Figure 6. Schematic representation of CFTR and CCIO mRNA ex-
pression at various levels of airway in human lung.
proximal bronchioles is consistent with CFTR expression pri-
marily in either a subpopulation of Clara cells or in another
nonciliated cell type. The previous demonstration of cAMP-
mediated Cl - transport in rabbit Clara cells ( 18) is consistent
with the presence ofCFTR in this cell type. Analysis in termi-
nal bronchioles, respiratory bronchioles, and alveoli revealed
substantial expression of CFTR in a large number of non-
CC 10-expressing cells; the identity ofthese nonciliated CFTR-
expressing cells in unknown. Our studies provide direct sup-
port for the role ofCFTR in distal airway disease ofthe human
adult CF lung. Furthermore, these studies suggest that alveolar
cells may be involved in primary pathogenesis.
The heterogeneous pattern of CFTR expression in distal
regions of the lung has implications on our understanding of
the basic biology of chloride transport in this tissue and may
help elucidate a better understanding ofthe pathophysiology of
lung diseases such as CF. These findings will likely affect the
approaches for gene therapy strategies for CF in that it will be
important to determine whether the CFTR gene must be di-
rected to specific cell types throughout the lung to prove effec-
tive.
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